Wealthfront Advisers LLC Dexcom Inc Transaction History

Wealthfront Advisers LLC

$43.4 Billion
Q4 2025

A detailed history of Wealthfront Advisers LLC transactions in Dexcom Inc stock. As of the latest transaction made, Wealthfront Advisers LLC holds 15,464 shares of DXCM stock, worth $897,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,464

Previous 10,889 42.01%

Holding current value

$897,839

Previous $732,000 22.54%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 30, 2026	BUY	$54.84 - $71.06 $250,893 - $325,099	4,575 Added 42.01%	15,464 $897,000
Q3 2025 Nov 06, 2025	BUY	$66.46 - $89.53 $22,795 - $30,708	343 Added 3.25%	10,889 $732,000
Q2 2025 Jul 31, 2025	BUY	$59.83 - $87.57 $61,146 - $89,496	1,022 Added 10.73%	10,546 $920,000
Q1 2025 May 02, 2025	SELL	$67.74 - $90.75 $1.17 Million - $1.57 Million	-17,309 Reduced 64.51%	9,524 $650,000
Q4 2024 Apr 01, 2025	BUY	$65.68 - $81.01 $1.68 Million - $2.08 Million	25,638 Added 2145.44%	26,833 $2.09 Million

Q4 2024 Feb 07, 2025	SELL	$65.68 - $81.01 $1.25 Million - $1.55 Million	-19,083 Reduced 94.11%	1,195 $92,000
Q3 2024 Nov 12, 2024	SELL	$64.0 - $116.06 $1.69 Million - $3.06 Million	-26,387 Reduced 56.55%	20,278 $1.36 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $113,178 - $144,101	1,026 Added 2.25%	46,665 $5.29 Million
Q1 2024 Apr 19, 2024	SELL	$114.22 - $140.1 $94,231 - $115,582	-825 Reduced 1.78%	45,639 $6.33 Million
Q4 2023 Feb 09, 2024	BUY	$75.49 - $124.16 $45,444 - $74,744	602 Added 1.31%	46,464 $5.77 Million
Q3 2023 Nov 01, 2023	BUY	$86.06 - $137.93 $230,038 - $368,686	2,673 Added 6.19%	45,862 $4.28 Million
Q2 2023 Aug 07, 2023	BUY	$112.47 - $130.98 $998,171 - $1.16 Million	8,875 Added 25.86%	43,189 $5.55 Million
Q1 2023 Apr 28, 2023	SELL	$104.0 - $122.92 $68,328 - $80,758	-657 Reduced 1.88%	34,314 $3.99 Million
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $227,151 - $327,896	2,673 Added 8.28%	34,971 $3.96 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $428,781 - $528,914	5,616 Added 21.05%	32,298 $2.6 Million
Q2 2022 Jul 20, 2022	BUY	$67.99 - $132.89 $1.62 Million - $3.17 Million	23,841 Added 839.18%	26,682 $1.99 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $85,424 - $118,221	-908 Reduced 24.22%	2,841 $1.45 Million
Q4 2021 Jan 21, 2022	BUY	$129.87 - $162.82 $304,415 - $381,650	2,344 Added 166.83%	3,749 $2.01 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $86,648 - $116,262	812 Added 136.93%	1,405 $768,000
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $8,503 - $11,332	-105 Reduced 15.04%	593 $253,000
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $139,055 - $171,773	-1,640 Reduced 70.15%	698 $251,000
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $18,330 - $24,557	235 Added 11.17%	2,338 $864,000
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $22,731 - $26,882	238 Added 12.76%	2,103 $867,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $116,898 - $196,459	1,865 New	1,865 $756,000

Others Institutions Holding DXCM

# of Institutions

1,084

Shares Held

374M

Call Options Held

6.86M

Put Options Held

7.17M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Account

Wealthfront Advisers LLC Dexcom Inc Transaction History